It’s been quite some time since my last blog post. We’ve been rather busy over the summer, so let me fill you in on what has happened. At Edge, we have been diligently working on our CLIA certification and offering, with our latest test offering a CLIA exome on our Illumina HiSeq2000 platform using either the Agilent SureSelect capture or Roche Nimblegen capture. Over the coming weeks the staff at Edge will be releasing a series of blog posts relating to targeted resequencing methodologies. They will relate specifically to Project Design, Research & Clinical applications, “Tools of the Trade”, Data Delivery and then a summary “Cheat Sheet”. They will be information heavy, with lots of tables and data to digest, so try not to read them right after a large meal.

Here at Edge we have designed our next generation sequencing lab from the ground up, with the goal of providing top quality, scalable services in a highly controlled environment.  We utilize the latest technologies in order to maintain our position at the cutting edge of next generation sequencing.  This virtual tour will take you through our various laboratories to give you a look inside our operation.  In each room there are clickable icons that provide details about the various instruments and products that we use.  Please take a minute to look around and see what we have built.

Please join us on June 20, 2012 from 10am-11am PT for "Towards A Medically Actionable Whole Genome Sequence" a free webinar with:

• Grant Campany - Senior Director, Archon Genomics X Prize presented by Express Scripts
• Justin H. Johnson - PhD Director of Bioionformatics, EdgeBio
• Marc Salit - PhD Group Leader, Biochemical Science Multiplexed Bimolecular Science, National Institute of Standards and Technology (NIST)
• Moderated by Kevin Davies - PhD editor in chief of Bio-IT World

We would like to thank Genomeweb for their recent articles regarding the announcement of our CLIA status. If you missed the articles from Genomeweb you can view them here:  Clinical Exome Sequencing and EdgeBio Recieves CLIA Certification

Request a Quote for your Exome Sequencing Project

A few weeks ago we received our CLIA certification for next generation sequencing and will offer clinical exome sequencing for large labs and hospitals that can do their own in-house analysis. We will supply aligned sequencing data and leave the interpretation to the customers themselves.

It was with great anticipation and excitement that we received our Certificate of Compliance yesterday from the US Dept. of Health and Human Services Centers for Medicare and Medicaid Services. This, paired with our compliance letter from the State of Maryland, means we have been deemed a CLIA lab and can begin to offer our Clinical Exome test under CLIA guidelines. It’s been quite a journey to get here and everyone is quite excited to receive this designation and achieve this milestone.